Cargando…
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
Induction of potent tumor-specific cytotoxic T-cell responses is a fundamental objective in anticancer therapeutic strategies. This event requires that antigen-presenting cells present tumor-associated antigens (Ag) on their MHC class-I molecule, in a process termed cross-presentation. Dendritic cel...
Autores principales: | Schiavoni, Giovanna, Mattei, Fabrizio, Gabriele, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872318/ https://www.ncbi.nlm.nih.gov/pubmed/24400008 http://dx.doi.org/10.3389/fimmu.2013.00483 |
Ejemplares similares
-
TIM-3 as a molecular switch for tumor escape from innate immunity
por: Mattei, Fabrizio, et al.
Publicado: (2013) -
The Tumor Microenvironment: A Pitch for Multiple Players
por: Schiavoni, Giovanna, et al.
Publicado: (2013) -
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α(+) Dendritic Cells
por: Schiavoni, Giovanna, et al.
Publicado: (2002) -
The dual role of IRF8 in cancer immunosurveillance
por: Schiavoni, Giovanna, et al.
Publicado: (2013) -
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
por: Afferni, Claudia, et al.
Publicado: (2018)